Neurological emergencies in children

Published on 27/02/2015 by admin

Filed under Anesthesiology

Last modified 27/02/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1637 times

Chapter 102 Neurological emergencies in children

Neurological emergencies are the most common life-threatening emergencies in children. In developed societies after the first year of life, the leading cause of death in childhood is injury, particularly traumatic brain injury. There is a range of conditions affecting the brain, spinal cord and peripheral nervous system that require prompt recognition, resuscitation and definitive management. The pathophysiology, clinical features, treatment and outcome of these acute neurological emergencies are influenced by several important differences between adults and children. These differences include response to injury, developmental maturity and capacity for growth and recovery.

PATHOPHYSIOLOGY OF BRAIN INJURIES IN CHILDREN

Brain injuries are usually caused by a primary event (e.g. trauma, ischaemia, infection or metabolic disturbance) and are frequently accompanied by secondary injuries including oedema, altered cerebrovascular autoregulation, tissue hypoxia or other cytotoxic events. It is unlikely that therapy administered after the event will influence the outcome of the primary injury. However, appropriate resuscitation and treatment and the avoidance of iatrogenic complications may prevent or reduce the impact of secondary injuries.

Features of brain injury particular to the paediatric patient are described below.

UNDIAGNOSED COMA

An ordered approach to diagnosis and treatment is required for a child with depressed conscious state of unknown origin. This approach must consider common life-threatening and rare treatable diseases (Table 102.1).

Table 102.1 Causes of coma in children

Structural Metabolic
Trauma Post-ictal state
Accidental Infection
Inflicted Meningitis
Hydrocephalus Encephalitis
Haemorrhage Drugs and toxins
AVM Hypoxia–ischaemia
Aneurysms Circulatory shock
Tumour Biochemical
Tumour Hypoglycaemia
Cerebral abscess Electrolyte disorders
Sodium/water
Calcium
Acid–base disturbance
Hyperthermia
Hepatic failure
Haemolytic–uraemic syndrome
Inborn errors of metabolism
Reye’s syndrome

CONTROLLED VENTILATION

Indications for ventilating a comatose child are:

Once ventilation is initiated the stomach should be drained with a gastric tube and blood pressure checked every 5 minutes. Raised ICP should be considered in any case of rapidly progressive coma. Intracranial hypertension should be managed with moderate hyperventilation and intravenous mannitol (0.25 g/kg). Hypertonic saline given as 0.5 ml/kg of 20% solution (3.4 mmol/ml) can also rapidly reduce ICP.2 Once stability is achieved, adequate sedation and analgesia is required. Muscle relaxants may be necessary to facilitate ventilation and prevent straining; however, their use precludes further neurological assessment and therefore, if long-acting muscle relaxants are continued, ICP monitoring is advisable. Hyperventilation is a short-term manoeuvre and following the early resuscitation phase, gradual return to a low-normal PaCO2 should be the aim. This is best achieved with end tidal CO2 and ICP monitoring. Particular attention should be paid to restoring intravascular volume and maintaining an adequate CPP.

STATUS EPILEPTICUS

Convulsive status epilepticus (CSE) is usually defined as a continuous convulsion lasting 30 minutes or longer or repeated convulsions lasting 30 minutes or longer without recovery of consciousness between convulsions.3 The common causes of CSE in children are:

PATHOPHYSIOLOGY

Many physiological changes occur during prolonged seizures. There is an initial phase of compensation lasting less than 30 minutes. Following a period of transition there is a phase of decompensation commencing between 30 and 60 minutes and evolving over hours. Physiological changes during the compensated phase include tachycardia, hypertension, increased catecholamine release and increased cardiac output. Changes within the brain include increased cerebral blood flow and increased cerebral utilisation of glucose and oxygen. After 30–60 minutes the mechanisms for homeostatic compensation fail. During the decompensated phase there may be falling blood pressure and cardiac output, hypoglycaemia, hypoxia, acidosis, electrolyte disturbance and rhabdomyolysis. The cerebral physiology is characterised by failing autoregulation and reduced cerebral blood flow and oxygen and glucose utilisation. Over hours a deficit in brain energy develops and this is associated with the development of brain damage.4

MANAGEMENT

The initial management is as for other neurological emergencies with attention to airway and oxygenation. Most seizures in childhood cease spontaneously in a short time, but if they persist for 5 minutes or continue after presentation to an emergency department, they should be stopped to avoid metabolic and ischaemic neuronal damage. Hypoglycaemia should be excluded or detected early. If intravenous access cannot be obtained rapidly, drugs can be administered intramuscularly, intranasally, rectally or via the intraosseous (i.o.) route. If benzodiazepines are administered within 20 minutes of a seizure commencing, the rate of seizure control is higher than if they are administered after 30 minutes.6 This justifies early prehospital administration of benzodiazepines to children with active seizures at the time of ambulance arrival.7 Specific drug treatment includes the following.

PARALDEHYDE

In many centres rectal paraldehyde (0.4 ml/kg mixed with an equal quantity of olive oil) is frequently used in the management of CSE.18 One advantage of paraldehyde is that, like diazepam, it can be administered rectally if i.v. access is difficult to obtain.

OUTCOME

The outcome of CSE is dependent on the aetiology. Neurologically normal children in whom CSE is precipitated by fever are considered to have a good prognosis with mortality reported between 0 and 2%.19 The incidence of neurological deficits or cognitive impairment in this group is also very low.5 In acute symptomatic CSE (where CSE is a symptom of an acute neurological process such as infection or trauma), mortality is 12–16% and the incidence of new neurological dysfunction is more than 20%.19 In this setting, however, it is very difficult to tease out the extent to which prolonged seizures contribute to neurological sequelae.

BACTERIAL MENINGITIS

MANAGEMENT

ANTIBIOTIC THERAPY

Empiric broad-spectrum antibiotics should be selected based on likely pathogens and local resistance patterns. A common protocol for BM is to use ampicillin plus cefotaxime for the first month of life and to use a third-generation cephalosporin (cefotaxime or ceftriaxone) after the first month.23 In regions where penicillin and cephalosporin-resistant Pneumococcus occurs, vancomycin should be added to the initial empiric antibiotics until the causative organism is identified and the antibiotic sensitivities are known. When cephalosporin-resistant pneumococci are found to be the causative organism in meningitis, both a third-generation cephalosporin and vancomycin should be continued as vancomycin penetrates into CSF poorly and therefore should not be used as a single antibiotic. The addition of rifampicin should be considered.24

ADJUVANT THERAPY

Buy Membership for Anesthesiology Category to continue reading. Learn more here